Clinical Trial Update: DiaCon Dual-Hormone Closed-Loop Glucose Control [Phase 2, Phase 3]

View source ↗

Summary

A DiaCon dual-hormone closed-loop glucose control trial for Type 1 diabetes has been withdrawn from Phase 2/Phase 3. The sponsor is Hvidovre University Hospital…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• DiaCon Dual-Hormone Closed-Loop Glucose Control

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Type 1 Diabetes | Phase 2, Phase 3 | Status: WITHDRAWN